California State Teachers Retirement System (CalSTRS)
KPTI icon

California State Teachers Retirement System (CalSTRS)’s Karyopharm Therapeutics KPTI Stock Holding History

California State Teachers Retirement System (CalSTRS)’s Portfolio KPTI Stock Details KPTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-759
Closed -$17.2K – 3143
2024
Q1 		$17.2K Sell
759
-484
-39% -$8.49K ﹤0.01% 2781
2023
Q4 		$16.1K Sell
1,243
-423
-25% -$5.7K ﹤0.01% 2942
2023
Q3 		$33.5K Sell
1,666
-6,860
-80% -$154K ﹤0.01% 2852
2023
Q2 		$229K Buy
8,526
+312
+4% +$13.4K ﹤0.01% 2534
2023
Q1 		$479K Sell
8,214
-73
-0.9% -$3.6K ﹤0.01% 2324
2022
Q4 		$423K Buy
8,287
+2,182
+36% +$151K ﹤0.01% 2414
2022
Q3 		$500K Buy
6,105
+73
+1% +$5.45K ﹤0.01% 2338
2022
Q2 		$408K Buy
6,032
+49
+0.8% +$4.49K ﹤0.01% 2474
2022
Q1 		$661K Sell
5,983
-464
-7% -$57.8K ﹤0.01% 2270
2021
Q4 		$622K Buy
6,447
+584
+10% +$58.2K ﹤0.01% 2434
2021
Q3 		$512K Sell
5,863
-756
-11% -$78.5K ﹤0.01% 2453
2021
Q2 		$1.02M Sell
6,619
-430
-6% -$62.4K ﹤0.01% 2205
2021
Q1 		$1.11M Sell
7,049
-26
-0.4% -$5.48K ﹤0.01% 2084
2020
Q4 		$1.64M Hold
7,075
– – ﹤0.01% 1756
2020
Q3 		$1.55M Buy
7,075
+27
+0.4% +$6.6K ﹤0.01% 1637
2020
Q2 		$2M Buy
7,048
+1,011
+17% +$299K ﹤0.01% 1475
2020
Q1 		$1.74M Sell
6,037
-30
-0.5% -$8.28K ﹤0.01% 1381
2019
Q4 		$1.75M Sell
6,067
-37
-0.6% -$8.03K ﹤0.01% 1652
2019
Q3 		$881K Buy
6,104
+176
+3% +$23.9K ﹤0.01% 2003
2019
Q2 		$533K Buy
5,928
+866
+17% +$69.5K ﹤0.01% 2320
2019
Q1 		$443K Hold
5,062
– – ﹤0.01% 2374
2018
Q4 		$711K Buy
5,062
+118
+2% +$19.9K ﹤0.01% 2089
2018
Q3 		$1.26M Sell
4,944
-2
-0% -$553 ﹤0.01% 1914
2018
Q2 		$1.26M Buy
4,946
+1,339
+37% +$331K ﹤0.01% 1912
2018
Q1 		$726K Buy
3,607
+55
+2% +$11K ﹤0.01% 2152
2017
Q4 		$511K Sell
3,552
-94
-3% -$15.1K ﹤0.01% 2394
2017
Q3 		$601K Sell
3,646
-344
-9% -$49.3K ﹤0.01% 2318
2017
Q2 		$542K Buy
3,990
+434
+12% +$64.2K ﹤0.01% 2423
2017
Q1 		$685K Sell
3,556
-167
-4% -$26.8K ﹤0.01% 2304
2016
Q4 		$525K Buy
3,723
+400
+12% +$54.1K ﹤0.01% 2487
2016
Q3 		$485K Buy
3,323
+20
+0.6% +$2.4K ﹤0.01% 2518
2016
Q2 		$332K Sell
3,303
-3
-0.1% -$390 ﹤0.01% 2703
2016
Q1 		$442K Buy
3,306
+451
+16% +$49.8K ﹤0.01% 2499
2015
Q4 		$568K Buy
2,855
+50
+2% +$10.8K ﹤0.01% 2350
2015
Q3 		$443K Sell
2,805
-7
-0.2% -$1.87K ﹤0.01% 2501
2015
Q2 		$1.15M Buy
2,812
+1,010
+56% +$437K ﹤0.01% 2021
2015
Q1 		$828K Buy
1,802
+126
+8% +$54.3K ﹤0.01% 2141
2014
Q4 		$941K Buy
1,676
+7
+0.4% +$3.98K ﹤0.01% 2091
2014
Q3 		$875K Buy
1,669
+162
+11% +$91.4K ﹤0.01% 2091
2014
Q2 		$1.05M Buy
1,507
+560
+59% +$261K ﹤0.01% 2028
2014
Q1 		$439K Hold
947
– – ﹤0.01% 2496
2013
Q4 		$325K Buy
+947
New +$262K ﹤0.01% 2683

Other funds holding KPTI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

California State Teachers Retirement System (CalSTRS)'s KPTI Position: Q2 2024 in Review

California State Teachers Retirement System (CalSTRS) sold out of Karyopharm Therapeutics (KPTI) in Q2 2024, closing a stake of 759 shares — an estimated $17.2K sold.

California State Teachers Retirement System (CalSTRS) first reported a position in KPTI in Q4 2013 and held it in 42 quarters. The position peaked at $2M in Q2 2020. 114 funds tracked by Wall St. Rank hold KPTI as of Q2 2024.

  • California State Teachers Retirement System (CalSTRS) reported no remaining Karyopharm Therapeutics position as of Q2 2024 after selling out during the quarter.
  • California State Teachers Retirement System (CalSTRS) sold 759 Karyopharm Therapeutics shares in Q2 2024, an estimated $17.2K.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Karyopharm Therapeutics in Q4 2013 and held it in 42 quarters.
  • California State Teachers Retirement System (CalSTRS)'s Karyopharm Therapeutics position peaked at $2M in Q2 2020.
  • 114 funds tracked by Wall St. Rank held Karyopharm Therapeutics as of Q2 2024.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2024, filed 14 Aug 2024.